美国 · SEC FORM 4
LEMAITRE VASCULAR INC
LMAT · Nasdaq · CIK 0001158895 · Healthcare · Medical Instruments & Supplies
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
5 sales · 9 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2020-08-26 · Roush John A.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,738,967
- 上期报告
- 1,693,134
- 日均成交量
- 253,231
- 回补天数
- 6.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
133 transaction lines in the latest 365-day window; 771 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Roush John A | 期权行权／转换 (M) | Common Stock | 3,444 | USD 48.60 | USD 167,378 | SEC 申报 ↗ |
| 2026-06-04 | LeMaitre George W | 赠与 (G) | Common Stock | 11,974 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | LeMaitre George W | 奖励／授予 (A) | Common Stock | 11,974 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Roush John A | 期权行权／转换 (M) | Common Stock | 3,444 | USD 48.60 | USD 167,378 | SEC 申报 ↗ |
| 2026-06-04 | LeMaitre George W | 赠与 (G) | Common Stock | 11,974 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | LeMaitre George W | 奖励／授予 (A) | Common Stock | 11,974 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-08 | LeMaitre George W | 卖出 (S) | Common Stock | 27,881 | USD 108.69 | USD 3,030,386 | SEC 申报 ↗ |
| 2026-05-08 | Kamke Trent G | 卖出 (S) | Common Stock | 2,928 | USD 107.00 | USD 313,296 | SEC 申报 ↗ |
| 2026-05-07 | Ross Bridget A | 卖出 (S) | Common Stock | 5,044 | USD 111.10 | USD 560,388 | SEC 申报 ↗ |
| 2026-05-07 | Ross Bridget A | 期权行权／转换 (M) | Common Stock | 5,044 | USD 48.15 | USD 242,882 | SEC 申报 ↗ |
| 2026-05-07 | LeMaitre George W | 卖出 (S) | Common Stock | 18,600 | USD 107.64 | USD 2,002,104 | SEC 申报 ↗ |
| 2026-05-07 | Jasinski Lawrence J | 卖出 (S) | Common Stock | 3,943 | USD 110.00 | USD 433,730 | SEC 申报 ↗ |
| 2026-05-07 | Jasinski Lawrence J | 期权行权／转换 (M) | Common Stock | 2,858 | USD 65.92 | USD 188,412 | SEC 申报 ↗ |
| 2026-04-22 | Pellegrino Joseph P JR | 期权行权／转换 (M) | Common Stock | 2,941 | USD 35.48 | USD 104,347 | SEC 申报 ↗ |
| 2026-03-11 | Roberts David B | 卖出 (S) | Common Stock | 3,312 | USD 107.68 | USD 356,602 | SEC 申报 ↗ |
| 2026-03-11 | Kamke Trent G | 卖出 (S) | Common Stock | 2,625 | USD 108.50 | USD 284,812 | SEC 申报 ↗ |
| 2026-03-11 | Kamke Trent G | 期权行权／转换 (M) | Common Stock | 2,625 | USD 35.48 | USD 93,135 | SEC 申报 ↗ |
| 2026-03-10 | LeBlanc Dorian Paul | 期权行权／转换 (M) | Common Stock | 2 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | LeBlanc Dorian Paul | 代扣税 (F) | Common Stock | 96 | USD 109.20 | USD 10,483 | SEC 申报 ↗ |
| 2026-03-02 | LeMaitre George W | 卖出 (S) | Common Stock | 55,930 | USD 107.81 | USD 6,029,813 | SEC 申报 ↗ |
| 2026-03-02 | LeMaitre George W | 赠与 (G) | Common Stock | 5,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-27 | Roberts David B | 卖出 (S) | Common Stock | 8,464 | USD 106.80 | USD 903,955 | SEC 申报 ↗ |
| 2026-02-27 | Kamke Trent G | 卖出 (S) | Common Stock | 1,044 | USD 110.29 | USD 115,143 | SEC 申报 ↗ |
| 2026-02-26 | SHADAN MARTHA | 期权行权／转换 (M) | Common Stock | 1 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | SHADAN MARTHA | 奖励／授予 (A) | Common Stock | 476 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Roush John A | 期权行权／转换 (M) | Common Stock | 1 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Roush John A | 奖励／授予 (A) | Common Stock | 476 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Ross Bridget A | 期权行权／转换 (M) | Common Stock | 1 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Ross Bridget A | 奖励／授予 (A) | Common Stock | 476 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Roberts David B | 期权行权／转换 (M) | Common Stock | 3 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Roberts David B | 代扣税 (F) | Common Stock | 147 | USD 113.69 | USD 16,712 | SEC 申报 ↗ |
| 2026-02-26 | Roberts David B | 奖励／授予 (A) | Common Stock | 1,660 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Pellegrino Joseph P JR | 期权行权／转换 (M) | Common Stock | 4 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LMAT |
| CIK | 0001158895 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 771 transaction lines from 2020-01-02 to 2026-09-01 3 P purchase lines · 159 S sale lines · 609 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.